Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,329 | -12,428 | -64,120 | -49,527 | -31,185 |
| Depreciation Amortization | 709 | 353 | 1,447 | 1,121 | 743 |
| Accounts receivable | -31 | -159 | -108 | -650 | -198 |
| Other Working Capital | -120 | -969 | -6,000 | -4,849 | -5,091 |
| Other Operating Activity | 1,369 | 54 | 17,171 | 15,909 | 9,062 |
| Operating Cash Flow | $-26,402 | $-13,149 | $-51,610 | $-37,996 | $-26,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,884 | 3,910 | 9 | -16,084 | -9,999 |
| PPE Investments | -42 | -20 | -75 | -53 | -53 |
| Investing Cash Flow | $7,842 | $3,890 | $-66 | $-16,137 | $-10,052 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,645 | 30,181 | 4,014 | 3,402 | 3,394 |
| Other Financing Activity | 1,441 | 1,470 | 0 | 0 | 0 |
| Financing Cash Flow | $32,086 | $31,651 | $4,014 | $3,402 | $3,394 |
| Beginning Cash Position | 117,967 | 117,967 | 165,629 | 165,629 | 165,629 |
| End Cash Position | 131,493 | 140,359 | 117,967 | 114,898 | 132,302 |
| Net Cash Flow | $13,526 | $22,392 | $-47,662 | $-50,731 | $-33,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,402 | -13,149 | -51,610 | -37,996 | -26,669 |
| Capital Expenditure | -42 | -20 | -75 | -53 | -53 |
| Free Cash Flow | -26,444 | -13,169 | -51,685 | -38,049 | -26,722 |